A buyback announcement like “₹1,000 per share” can quickly catch attention, especially when the stock is trading lower in the market. For many investors, the first instinct is simple: buy now, tender later, and capture the difference. But with the Windlas Biotech buyback 2026, the real question is not just about the premium. It is […]
For many people, becoming a High Net Worth Individual feels like the financial finish line. A larger home, luxury travel, exclusive banking access, and premium investment opportunities often dominate the public image of HNI life. Yet people searching for “benefits of being HNI” usually begin to realise something surprising after crossing a certain wealth level. […]
Many investors reach a point where traditional options such as mutual funds, fixed deposits, and direct equities no longer cover every investment objective. At that stage, curiosity often turns toward Alternative Investment Funds. However, the terminology can feel complex, and many investors are unsure whether these products are meant only for ultra-high-net-worth individuals. If you […]
inXits is India’s SEBI-registered Investment Advisor, Research Analyst and AMFI registered Mutual Fund Distributor. Manage all your investments, bank accounts and loans in one-place with certified professional backed guidance — 24/7 free support.
SEBI Registered7,000+ FamiliesISO 27001 CertifiedFree to Start